Unicycive Therapeutics In...

NASDAQ: UNCY · Real-Time Price · USD
4.71
0.08 (1.73%)
At close: Aug 15, 2025, 3:59 PM
4.73
0.53%
After-hours: Aug 15, 2025, 06:35 PM EDT

Unicycive Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
26.14M 9.7M 455K 16.58M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a -174K -333K
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
939K 325K 159K 126K
Total Current Assets
30.95M 13.4M 2.64M 18.41M
Property-Plant & Equipment
720K 792K 174K 333K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
720K 792K 174K 333K
Total Assets
31.67M 14.19M 2.82M 18.74M
Account Payables
966K 821K 846K 713K
Deferred Revenue
n/a -18K n/a n/a
Short-Term Debt
564K 18K 155K 151K
Other Current Liabilities
18.94M 13.12M -109K -122K
Total Current Liabilities
24.12M 17.53M 3.28M 2.1M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
117K 466K 1.05K 155K
Total Liabilities
24.24M 18M 3.28M 2.26M
Total Debt
773K 811K 155K 306K
Common Stock
114K 35K 15K 15K
Retained Earnings
-101.27M -64.54M -34M -15.94M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
7.43M -3.81M -466K 16.48M
Total Investments
n/a n/a n/a n/a